# D-serine Adjuvant Treatment for Parkinson's Disease

> **NCT00215904** · PHASE4 · COMPLETED · sponsor: **Herzog Hospital** · enrollment: 13 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** D-serine (~2g/day)

## Key facts

- **NCT ID:** NCT00215904
- **Lead sponsor:** Herzog Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00215904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00215904, "D-serine Adjuvant Treatment for Parkinson's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00215904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*